NTRK3 methylation has been reported in other tumours73 and although tyrosine kinase inhibitors are widely available for NTRK-translocated tumours, the effect of these TRK inhibitors has not been explored in tumours with NTRK gain or loss due to methylation. This evidence concerns the gene NTRK1 and neoplasm.